English language version of China
Given China's entry into the World Trade Organization and its rapid economic growth in the past decade, there is growing international interest in this, the world's largest emerging market.
As a result, Canada-based Business Data International has announced the publication of an English version of the Chinese Pharmacopoeia, compiled by the Pharmacopoeia Commission of China's Ministry of Public Health.
This three-volume publication, claimed to be the only authoritative collection of standards for Chinese medical substances, is available for $1,199 plus 10% airmail postage from: Business Data International, 85 Perron Street, La Prairie, Montreal, QC J5R 5Z5, Canada. Fax: (514) 221-3281; e-mail: info@businessdataint.com; web site: www.businessdataint.com.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze